Format

Send to

Choose Destination
Curr Opin Biotechnol. 1996 Dec;7(6):659-66.

Gram-positive commensal bacteria for mucosal vaccine delivery.

Author information

1
The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA. vaf@rockvax.rockefeller.edu

Abstract

To avoid the use of engineered pathogens for vaccine delivery, systems have been developed that allow the expression of heterologous antigens in commensal Gram-positive bacteria. In some cases, both a serum IgG and secretory IgA response are induced to the recombinant protein after vaccination, verifying the validity of the approach. These live recombinant bacteria may be used in the future to introduce a protective immune response to pathogenic microorganisms after mucosal colonization.

PMID:
8939641
DOI:
10.1016/s0958-1669(96)80079-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center